Gates Package — page 211

G1 - NIAID DIR collaborative agreements active between June 1 2016 and Dec 13 2023 Reference# I Agreement Type Effective Date Expiration Dz External Parties *Lead Pl Bill & Melinda Gates Foundation (BMGF), 2016-0537 Gift 11/10/2016] 12/31/2017] University of Maryland, Baltimore (UMB) 2016-0543 CTA - Clinical Trial Agreement 7/5/2018} Rockefeller University Tae Wook Chun 2016-0543 CTA - Clinical Trial Agreement 7/5/2018} Rockefeller University Tae Wook Chun University of Texas Medical Branch at Galveston 2016-0567 Research Collaboration Agreement 7/1/2016 7/1/2018} (UTMB) [US] 2016-0572 Research Collaboration Agreement 8/30/2016] 8/30/2020]Food and Drug Administration (FDA) Mathew Memoli 2016-0572 Research Collaboration Agreement 8/30/2016] 8/30/2020]Food and Drug Administration (FDA) Mathew Memoli Merck & Co., Inc. (currently Merck, Sharp, and 2016-0578 Research Collaboration Agreement 3/20/2017 Dohme) Raphaela Goldbac GLAXO WELLCOME, INC. (now GlaxoSmithKline; 2016-0605 Letter of Intent/MOU 6/17/2016] GSK) Paneez Khoury GLAXO WELLCOME, INC. (now GlaxoSmithKline; 2016-0605 Letter of Intent/MOU 6/17/2016 GSK) Paneez Khoury 2016-0610 Research Collaboration Agreement 12/5/2016] 12/5/2019|George Washington University (GWU) Patrizia FARCI 2016-0612 Research Collaboration Agreement 8/9/2016 8/9/2019] Boston Children's Hospital Steven Holland Chinese Academy of Medical Sciences and Peking 2016-0619 Research Collaboration Agreement 8/4/2016 8/4/2019} Union Medical College [CN] Jeffery Taubenber Chinese Academy of Medical Sciences and Peking 2016-0619 Research Collaboration Agreement 8/4/2016 8/4/2019] Union Medical College [CN] Jeffery Taubenber 2016-0643 Gift 8/24/2016 International Biomedical Research Alliance Steven Holland 2016-0663 Letter of Intent/MOU 7/5/2016] GlaxoSmithKline LLC (GSK) Amy Klion 2016-0663 Letter of Intent/MOU 7/5/2016} GlaxoSmithKline LLC (GSK) Amy Klion 2016-0663 Letter of Intent/MOU 7/5/2016] GlaxoSmithKline LLC (GSK) Amy Klion 2016-0663 Letter of Intent/MOU 7/5/2016} GlaxoSmithKline LLC (GSK) Amy Klion 2016-0663 Letter of Intent/MOU 7/5/2016] GlaxoSmithKline LLC (GSK) Amy Klion 2016-0671 Research Collaboration Agreement 7/14/2016] 7/14/2021|Gene By Gene, LTD 2016-0671 Research Collaboration Agreement 7/14/2016] 7/14/2021|Gene By Gene, LTD 2016-0671 Research Collaboration Agreement 7/14/2016] 7/14/2021|Gene By Gene, LTD Joshua Milner 2016-0672 Research Collaboration Agreement 1/27/2017| 1/27/2019|Abbott Laboratories, Inc. [US] Thomas Quinn 2016-0680 CRADA 8/21/2017| _8/21/2022|Swedish Orphan Biovitrum AB [SE] Raphaela Goldbac 2016-0698 Research Collaboration Agreement 8/23/2016 Antigen Discovery Inc. Patrick Duffy 2016-0731 Research Collaboration Agreement 11/2/2016] 11/7/2017]Centers for Disease Control and Prevention (CDC) Heinrich Feldmann 2016-0744 Research Collaboration Agreement 8/24/2016] 8/24/2019|COMMENCE BIO, INC.